Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Intercept Pharmaceuticals (NQ: ICPT ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Nov 7, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 18.92 (39) Ask (Size) 19.02 (1,075) Prev. Close 19.00 Today's Range N/A - N/A 52wk Range 9.850 - 19.02 Shares Outstanding 41,782,727 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CymaBay Therapeutics Deal May Not Be Needle Moving For $100B Valued Gilead, But Acquisition Is Reasonably Priced: Analyst February 13, 2024 Gilead's acquisition of CymaBay Therapeutics for $4.3 billion strengthens its liver disease portfolio. Analysts see potential in seladelpar's impact on PBC and pruritus, projecting peak sales of $800... Via Benzinga Top 5 Health Care Stocks That Should Keep You Up At Night October 26, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga Performance More News Read More Stocks to Sell: 7 Overbought Companies You Ought to Dump Right Now October 19, 2023 Via InvestorPlace INTERCEPT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intercept Pharmaceuticals, Inc. - ICPT October 16, 2023 From Kahn Swick & Foti, LLC Via Business Wire Analyst Expectations for Intercept Pharma's Future September 27, 2023 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intercept Pharmaceuticals, Inc. (Nasdaq – ICPT), Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq – October 03, 2023 From Brodsky & Smith LLC Via GlobeNewswire 10 Health Care Stocks Whale Activity In Today's Session October 02, 2023 Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session September 28, 2023 Via Benzinga INTERCEPT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intercept Pharmaceuticals, Inc. - ICPT September 27, 2023 From Kahn Swick & Foti, LLC Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023 September 27, 2023 Via Benzinga Why Intercept Pharmaceuticals Stock Is Skyrocketing Today September 26, 2023 Via The Motley Fool Why Is Intercept Pharmaceuticals (ICPT) Stock Up 75% Today? September 26, 2023 Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Intraday Session September 26, 2023 Via Benzinga Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session September 26, 2023 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intercept Pharmaceuticals, Inc. (Nasdaq – ICPT), Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq – September 26, 2023 From Brodsky & Smith LLC Via GlobeNewswire Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday September 26, 2023 Via Benzinga Topics Stocks Exposures US Equities Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) is a Leading Gainer in Tuesday Morning Trading September 26, 2023 Via Investor Brand Network Dow Tumbles 150 Points; US House Prices Rise in July September 26, 2023 Via Benzinga Topics Stocks Exposures US Equities Why Is Rare Liver Disease Focused Intercept Pharmaceuticals Stock Trading Higher Today? September 26, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session September 26, 2023 Via Benzinga ICPT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intercept Pharmaceuticals, Inc. Is Fair to Shareholders September 26, 2023 From Halper Sadeh LLC Via Business Wire Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session September 22, 2023 Via Benzinga Investors Eye CymaBay's AFFIRM Study As Regulatory Uncertainties Ease September 21, 2023 Via Benzinga Why CymaBay Therapeutics Stock Is Jumping Today September 08, 2023 Via The Motley Fool Why CymaBay, With 172% Growth This Year, Just Surged For A Second Day Running September 08, 2023 Via Investor's Business Daily Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.